Neuroendocrine adenoma middle ear
Neuroendocrine Adenoma of the Middle Ear[edit | edit source]
Neuroendocrine adenoma of the middle ear (NAME) is a rare type of tumor that occurs in the middle ear. It is characterized by the presence of both neuroendocrine and glandular components, which can make diagnosis challenging. These tumors are generally benign but can exhibit locally aggressive behavior.
Clinical Presentation[edit | edit source]
Patients with neuroendocrine adenoma of the middle ear typically present with symptoms related to the ear. Common symptoms include:
- Hearing loss
- Tinnitus
- Otalgia (ear pain)
- Otorrhea (ear discharge)
These symptoms are often similar to those of other middle ear conditions, which can delay diagnosis.
Pathophysiology[edit | edit source]
Neuroendocrine adenomas of the middle ear are thought to arise from the epithelial cells of the middle ear mucosa. They exhibit both neuroendocrine and glandular differentiation, which is evident upon histological examination. The tumors are composed of small, uniform cells with round nuclei and scant cytoplasm, arranged in nests or trabeculae.
Diagnosis[edit | edit source]
The diagnosis of NAME is primarily based on histopathological examination. A biopsy of the tumor is performed, and the tissue is examined under a microscope. Immunohistochemical staining is often used to confirm the presence of neuroendocrine markers such as chromogranin A, synaptophysin, and neuron-specific enolase.
Treatment[edit | edit source]
The primary treatment for neuroendocrine adenoma of the middle ear is surgical excision. Complete removal of the tumor is the goal to prevent recurrence. In some cases, additional treatments such as radiation therapy may be considered, especially if the tumor is not completely resectable or if there is evidence of aggressive behavior.
Prognosis[edit | edit source]
The prognosis for patients with neuroendocrine adenoma of the middle ear is generally favorable, especially when the tumor is completely excised. Recurrence is possible, particularly if the tumor is not fully removed. Long-term follow-up is recommended to monitor for any signs of recurrence.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
